These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9106497)

  • 1. Blood group B glycosphingolipids in alpha-galactosidase deficiency (Fabry disease): influence of secretor status.
    Ledvinová J; Poupetová H; Hanácková A; Písacka M; Elleder M
    Biochim Biophys Acta; 1997 Apr; 1345(2):180-7. PubMed ID: 9106497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases.
    Asfaw B; Ledvinová J; Dobrovolńy R; Bakker HD; Desnick RJ; van Diggelen OP; de Jong JG; Kanzaki T; Chabas A; Maire I; Conzelmann E; Schindler D
    J Lipid Res; 2002 Jul; 43(7):1096-104. PubMed ID: 12091494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.
    Stapleton A; Nudelman E; Clausen H; Hakomori S; Stamm WE
    J Clin Invest; 1992 Sep; 90(3):965-72. PubMed ID: 1522244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group A glycosphingolipid accumulation in the hair of patients with alpha-N-acetylgalactosaminidase deficiency.
    Kimura A; Kanekura T; Saito Y; Sagawa K; Nosaka M; Kanzaki T; Tsuji T
    Life Sci; 2005 Mar; 76(16):1817-24. PubMed ID: 15698859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy for Fabry disease: morphologic and histochemical changes in the urinary sediments.
    Utsumi K; Mitsuhashi F; Asahi K; Sakurazawa M; Arii K; Komaba Y; Katsumata T; Katsura K; Kase R; Katayama Y
    Clin Chim Acta; 2005 Oct; 360(1-2):103-7. PubMed ID: 16112661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific storage of glycoconjugates with terminal α-galactosyl moieties in the exocrine pancreas of Fabry disease patients with blood group B.
    Rybová J; Kuchar L; Hulková H; Asfaw B; Dobrovolný R; Sikora J; Havlícek V; Škultéty L; Ledvinová J
    Glycobiology; 2018 Jun; 28(6):382-391. PubMed ID: 29548035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human GII.4 norovirus VLP induces membrane invaginations on giant unilamellar vesicles containing secretor gene dependent α1,2-fucosylated glycosphingolipids.
    Rydell GE; Svensson L; Larson G; Johannes L; Römer W
    Biochim Biophys Acta; 2013 Aug; 1828(8):1840-5. PubMed ID: 23528203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of blood-group-ABO(H)-active glycosphingolipids in type-AB human erythrocytes.
    Kushi Y; Tsunoda A; Komatsuzaki A; Watanabe K; Kasama T; Handa S
    Eur J Biochem; 1995 Aug; 231(3):862-7. PubMed ID: 7649187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation and comparison of the contents of blood group B antigens in selected human tissues by microphotometric quantification of Griffonia simplicifolia agglutinin I-B4 staining with or without prior alpha-galactosidase digestion.
    Ito N; Nagaike C; Morimura Y; Hatake H
    Histol Histopathol; 1997 Apr; 12(2):415-24. PubMed ID: 9151130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microscale analysis of glycosphingolipids by TLC blotting/secondary ion mass spectrometry: a novel blood group A-active glycosphingolipid and changes in glycosphingolipid expression in rat mammary tumour cells with different metastatic potentials.
    Kasama T; Hisano Y; Nakajima M; Handa S; Taki T
    Glycoconj J; 1996 Jun; 13(3):461-9. PubMed ID: 8781977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of glycosphingolipid-based blood group antigen expression on erythrocytes and in plasma studied on consecutive samples after a blood group O to A bone marrow transplantation.
    Lindström K; Shanwell A; Jacobsson A; Lönnqvist B; Samuelsson BE
    Glycobiology; 1992 Dec; 2(6):529-34. PubMed ID: 1472759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neutral glycosphingolipids of Fabry's disease lymphoblastoid lines established by Epstein-Barr virus transformation].
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Eur J Biochem; 1985 Feb; 147(1):77-82. PubMed ID: 2982612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical fingerprinting of non-acid glycosphingolipids in meconium of a human individual of blood group B Le(a-b+) and secretor.
    Angström J; Falk KE; Karlsson KA; Larson G
    Biochim Biophys Acta; 1982 Aug; 712(2):274-82. PubMed ID: 7126605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status.
    Cordon-Cardo C; Lloyd KO; Finstad CL; McGroarty ME; Reuter VE; Bander NH; Old LJ; Melamed MR
    Lab Invest; 1986 Oct; 55(4):444-54. PubMed ID: 2429066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy.
    Quinta R; Rodrigues D; Assunção M; Macedo MF; Azevedo O; Cunha D; Oliveira P; Sá Miranda MC
    Gene; 2014 Feb; 536(1):97-104. PubMed ID: 24334116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases.
    Ferraz MJ; Marques AR; Appelman MD; Verhoek M; Strijland A; Mirzaian M; Scheij S; Ouairy CM; Lahav D; Wisse P; Overkleeft HS; Boot RG; Aerts JM
    FEBS Lett; 2016 Mar; 590(6):716-25. PubMed ID: 26898341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased urinary excretion of glycosphingolipids in familial hypercholesterolemia.
    Chatterjee S; Sekerke CS; Kwiterovich PO
    J Lipid Res; 1982 May; 23(4):513-22. PubMed ID: 6808069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation.
    Orntoft TF; Greenwell P; Clausen H; Watkins WM
    Gut; 1991 Mar; 32(3):287-93. PubMed ID: 1826491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of at least two different H-blood-group-related beta-D-gal alpha-2-L-fucosyltransferases in human serum and the genetics of blood group H substances.
    Le Pendu J; Cartron JP; Lemieux RU; Oriol R
    Am J Hum Genet; 1985 Jul; 37(4):749-60. PubMed ID: 9556663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosphingolipid patterns of the epithelial and non-epithelial compartments of rat large intestine.
    Hansson GC; Karlsson KA; Thurin J
    Biochim Biophys Acta; 1984 Mar; 792(3):281-92. PubMed ID: 6696935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.